Replies to post #5069 on BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

Reversetaxman,

I sold just prior to the Abbott news (Original Agreement) and bought back in immediately following the agreement.

I made up my mind some time back that I will not sell my position in BOCX.

I look at it as you only live once. If the stock goes to -0- then so be it...But the immense possibilities that this stock presents far outweigh the waiting game.

I do tend to look at the glass as HALF FULL but I would never forgive myself if I were to miss this train.

[erthang]

Reversetaxman: I believe the reason you haven't heard anything from Abbott in so long is because Abbott has no incentive to say anything! I know you are biased in your thinking because you are seeing your investment dwindling, but be logical for one moment. There is no benefit for Abbott stating publicly the progress of recaf development. Complete terms of the licensing agreement aren't public, but we do know that Abbott can return the license with no further obligation at anytime, but they have not (after 18 mos). That is a very positive sign when viewed along the positive statements about the progress from Biocurex, and with the knowledge that Abbott won't make any public statements until they are ready to trigger the milestone payment which will be in the millions.

I like the skepticism surrounding this stock and the pink sheet trading, because it is creating a wonderful buying opportunity. My next purchase price will be @ .43 to bring down my purchasing avg to under a dollar.